EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer—2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent

医学 前列腺癌 放射治疗 医学物理学 癌症 放射科 内科学
作者
Philip Cornford,Roderick C.N. van den Bergh,Erik Briers,Thomas Van den Broeck,Oliver Brunckhorst,Julie Darraugh,Daniel Eberli,Gert De Meerleer,Maria De Santis,Andrea Farolfi,Giorgio Gandaglia,Silke Gillessen,Nikolaos Grivas,Ann Henry,Michael Lardas,Geert J.L.H. van Leenders,Matthew Liew,Estefanía Linares,Jan Oldenburg,Inge M. van Oort,Daniela E. Oprea‐Lager,Guillaume Ploussard,Matthew J. Roberts,Olivier Rouvière,Ivo G. Schoots,Natasha Schouten,Emma Jane Smith,Johan Stranne,Thomas Wiegel,Peter-Paul Willemse,Derya Tilki
出处
期刊:European Urology [Elsevier]
卷期号:86 (2): 148-163 被引量:88
标识
DOI:10.1016/j.eururo.2024.03.027
摘要

The European Association of Urology (EAU)-European Association of Nuclear Medicine (EANM)-European Society for Radiotherapy and Oncology (ESTRO)-European Society of Urogenital Radiology (ESUR)-International Society of Urological Pathology (ISUP)-International Society of Geriatric Oncology (SIOG) guidelines provide recommendations for the management of clinically localised prostate cancer (PCa). This paper aims to present a summary of the 2024 version of the EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on the screening, diagnosis, and treatment of clinically localised PCa. The panel performed a literature review of all new data published in English, covering the time frame between May 2020 and 2023. The guidelines were updated, and a strength rating for each recommendation was added based on a systematic review of the evidence. A risk-adapted strategy for identifying men who may develop PCa is advised, generally commencing at 50 yr of age and based on individualised life expectancy. The use of multiparametric magnetic resonance imaging in order to avoid unnecessary biopsies is recommended. When a biopsy is considered, a combination of targeted and regional biopsies should be performed. Prostate-specific membrane antigen positron emission tomography imaging is the most sensitive technique for identifying metastatic spread. Active surveillance is the appropriate management for men with low-risk PCa, as well as for selected favourable intermediate-risk patients with International Society of Urological Pathology grade group 2 lesions. Local therapies are addressed, as well as the management of persistent prostate-specific antigen after surgery. A recommendation to consider hypofractionation in intermediate-risk patients is provided. Patients with cN1 PCa should be offered a local treatment combined with long-term intensified hormonal treatment. The evidence in the field of diagnosis, staging, and treatment of localised PCa is evolving rapidly. These PCa guidelines reflect the multidisciplinary nature of PCa management. This article is the summary of the guidelines for "curable" prostate cancer. Prostate cancer is "found" through a multistep risk-based screening process. The objective is to find as many men as possible with a curable cancer. Prostate cancer is curable if it resides in the prostate; it is then classified into low-, intermediary-, and high-risk localised and locally advanced prostate cancer. These risk classes are the basis of the treatments. Low-risk prostate cancer is treated with "active surveillance", a treatment with excellent prognosis. For low-intermediary-risk active surveillance should also be discussed as an option. In other cases, active treatments, surgery, or radiation treatment should be discussed along with the potential side effects to allow shared decision-making.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
猫的房东完成签到,获得积分20
2秒前
彩色的凌旋完成签到,获得积分10
4秒前
7秒前
9秒前
盼盼完成签到,获得积分10
10秒前
悠游发布了新的文献求助10
14秒前
善学以致用应助猫的房东采纳,获得10
15秒前
科研通AI2S应助shitou采纳,获得10
15秒前
科研通AI2S应助hebhm采纳,获得10
17秒前
桥本完成签到 ,获得积分10
20秒前
冷酷凌寒发布了新的文献求助10
23秒前
日富一日完成签到,获得积分10
26秒前
29秒前
臧真完成签到 ,获得积分10
32秒前
Zhouxiaoyuan完成签到 ,获得积分20
35秒前
菜鸟发布了新的文献求助10
35秒前
Kail完成签到,获得积分10
37秒前
小二郎应助hhh采纳,获得10
37秒前
在水一方应助张秋雨采纳,获得10
39秒前
haofan17完成签到,获得积分10
39秒前
Willer完成签到,获得积分10
43秒前
星辰大海应助菜鸟采纳,获得10
44秒前
45秒前
46秒前
爆米花应助Czd采纳,获得10
48秒前
Somnolence咩完成签到,获得积分10
48秒前
猫的房东发布了新的文献求助10
48秒前
hlxhlx完成签到,获得积分10
51秒前
霸气以菱完成签到 ,获得积分10
53秒前
张秋雨完成签到,获得积分20
54秒前
54秒前
昵称不可为空完成签到,获得积分10
56秒前
YOMU完成签到,获得积分10
56秒前
58秒前
y大哥略略略完成签到,获得积分10
58秒前
JACk发布了新的文献求助10
59秒前
1分钟前
蒋海应助张秋雨采纳,获得10
1分钟前
hyy发布了新的文献求助10
1分钟前
B314ZJH发布了新的文献求助10
1分钟前
高分求助中
Sustainability in Tides Chemistry 2000
Pharmacogenomics: Applications to Patient Care, Third Edition 1000
Studien zur Ideengeschichte der Gesetzgebung 1000
TM 5-855-1(Fundamentals of protective design for conventional weapons) 1000
Genera Insectorum: Mantodea, Fam. Mantidæ, Subfam. Hymenopodinæ (Classic Reprint) 800
Ethnicities: Media, Health, and Coping 700
Development of a new synthetic process for the synthesis of (S)-methadone and (S)- and (R)-isomethadone as NMDA receptor antagonists for the treatment of depression 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3089129
求助须知:如何正确求助?哪些是违规求助? 2741271
关于积分的说明 7564185
捐赠科研通 2391538
什么是DOI,文献DOI怎么找? 1268286
科研通“疑难数据库(出版商)”最低求助积分说明 614044
版权声明 598684